What is it about?
The objective of this experiment was to study the effect of CL 316,243 (CL) (a highly selective β3-adrenergic receptor agonist) on cellular changes occurring in retroperitoneal white adipose tissue (RWAT) of lean and obese rats.
Featured Image
Why is it important?
Development of thermogenic drugs for the treatment of obesity has now focused on selective β3-adrenergic agonists. It has been postulated that thermogenic drugs might stimulate thermogenesis in BAT and induce lipolysis of WAT.
Perspectives
Treatment of both lean and obese Zucker rats with CL induces extensive remodeling of RWAT that includes shrinkage of white adipose tissue, the appearance of abundant multilocular cells in RWAT together with the appearance of a marked increase of UCP, preferentially in lean rats.
Dr Masoud Ghorbani
Pasteur Institute of Iran
Read the Original
This page is a summary of: Apparent histological changes of adipocytes after treatment with CL 316,243, a ß-3-adrenergic receptor agonist, Drug Design Development and Therapy, February 2015, Taylor & Francis,
DOI: 10.2147/dddt.s73891.
You can read the full text:
Contributors
The following have contributed to this page
